Alexis A, Anders K, Seetasith A, Holden M. Comparison of Study Designs for Primary Phase III Trials for Omalizumab Versus Dupilumab for Patients With Chronic Spontaneous Urticaria. J of Skin [Internet]. 2023Nov.13 [cited 2024Jul.3];7(6):s299. Available from: https://jofskin.org/index.php/skin/article/view/2367